Prospective Evaluation of 18F-DCFPyL PET/CT and Conventional Imaging in Patients with Biochemically Recurrent Prostate Cancer

被引：0
|
作者：
Song, Hong [1 ]
Harrison, Caitlyn [1 ]
Guja, Kip [1 ]
Franc, Benjamin [1 ]
Moradi, Farshad [1 ]
Davidzon, Guido [1 ]
Aparici, Carina Mari [1 ]
Iagaru, Andrei [1 ]
机构：
[1] Stanford Univ, Dept Radiol Nucl Med, Stanford, CA 94305 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
652
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
    Jansen, Bernard H. E.
    Cysouw, Matthijs C. F.
    Vis, Andre N.
    van Moorselaar, Reindert J. A.
    Voortman, Jens
    Bodar, Yves J. L.
    Schober, Patrick R.
    Hendrikse, N. Harry
    Hoekstra, Otto S.
    Boellaard, Ronald
    Oprea-Lager, D. E.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (09) : 1320 - 1325
  • [42] Re: "Overcoming Challenges Associated with 18F-DCFPyL PET Imaging in Prostate Cancer"
    Rowe, Steven P.
    Voter, Andrew F.
    Werner, Rudolf A.
    Zukotynski, Katherine A.
    Pomper, Martin G.
    Gorin, Michael A.
    Solnes, Lilja B.
    CANADIAN JOURNAL OF UROLOGY, 2023, 30 (02)
  • [43] [18F]DCFPyL PET/CT for Imaging of Prostate Cancer
    Rowe, Steven P.
    Buck, Andreas
    Bundschuh, Ralph A.
    Lapa, Constantin
    Serfling, Sebastian E.
    Derlin, Thorsten
    Higuchi, Takahiro
    Gorin, Michael A.
    Pomper, Martin G.
    Werner, Rudolf A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (03): : 240 - 246
  • [44] A Preliminary Retrospective Experience on 18F-DCFPYL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
    Lopez Prior, V.
    Manchon-Adsuar, F.
    Diaz-Exposito, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S451 - S451
  • [45] Prospective evaluation of 18F- DCFPyL in Patients with Biochemically Recurrent Prostate Cancer: Positivity Rate and Correlation with PSA levels
    Harrison, Caitlyn
    Song, Hong
    Franc, Benjamin L.
    Guja, Kip
    Moradi, Farshad
    Davidzon, Guido
    Aparici, Carina Mari
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [46] A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY).
    Morris, Michael J.
    Carroll, Peter
    Probst, Stephan
    Pouliot, Frederic
    Saperstein, Lawrence
    Siegel, Barry A.
    Alva, Ajjai Shivaram
    Preston, Mark A.
    Patnaik, Akash
    Gorin, Michael A.
    Durack, Jeremy C.
    Nichols, Melissa
    Lin, Tess
    Strack, Thomas
    DiPippo, Vincent A.
    Jensen, Jessica Donato
    Mahmood, Syed
    Wong, Vivien
    Pienta, Kenneth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Curative Therapy Choice and Lesion Detection by 18F-DCFPyL and Multiparametric MRI in Biochemically Recurrent Prostate Cancer
    Lindenberg, Liza
    Mena, Esther
    Turkbey, Baris
    Shih, Joanna
    Bergvall, Ethan
    Adler, Stephen
    Lin, Frank
    Ton, Anita
    McKinney, Yolanda
    Citrin, Deborah
    Madan, Ravi
    Dahut, William
    Choyke, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [48] Prostate Cancer Lymphangitic Pulmonary Carcinomatosis Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT
    Zukotynski, Katherine A.
    Jadvar, Hossein
    Potvin, Kylea
    Cho, Steve Y.
    Kim, Chun Ki
    Winquist, Eric
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (09) : 727 - 729
  • [49] Deep Learning for Automatic Prostate Segmentation On 18F-DCFPyL PET/CT In Prostate Cancer.
    Cysouw, M.
    Luining, W. I.
    de Vries, B. M.
    Oprea-Lager, D. E.
    Vis, A. N.
    Boellaard, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S732 - S732
  • [50] Prospective intraindividual comparison of 18F-PSMA-7Q and 18F-DCFPyL PET/CT in patients with newly diagnosed prostate cancer
    Liu, Yachao
    Zhang, Xiaojun
    Liu, Jiajin
    Zhang, Jinming
    Xu, Baixuan
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (06) : 725 - 730
12345